| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |